Originator	Generic Name	World Status	Any Therapy Code	Any Therapy Description
ActivBiotics	ABI-0299	Preclinical	J3Z	Antibacterial, other
Barr Pharmaceuticals	azithromycin	Launched	J1F J4A S2	Macrolide antibiotic Antimycobacterial Otological
Kaneka	rifalazil	Phase III Clinical Trial	J3Z J4A	Antibacterial, other Antimycobacterial
Kyorin	gatifloxacin	Launched	J3C J4A	Quinolone antibacterial Antimycobacterial
Meiji Seika	midecamycin acetate	Launched	J1F	Macrolide antibiotic
Sanofi-Aventis	rosoxacin	Launched	J3C	Quinolone antibacterial
Sanofi-Aventis	roxithromycin	Launched	J1F	Macrolide antibiotic
Table 1. Drug candidates in development or launched for the treatment of bacterial STIs